New Zealand markets closed

GlycoMimetics, Inc. (GLYC)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.2630-0.0075 (-2.77%)
At close: 04:00PM EDT
0.2629 -0.00 (-0.04%)
After hours: 06:33PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 16.95M
Enterprise value -13.70M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.69k
Price/book (mrq)0.59
Enterprise value/revenue 555.40
Enterprise value/EBITDA -0.48

Trading information

Stock price history

Beta (5Y monthly) 2.14
52-week change 3-86.17%
S&P500 52-week change 323.76%
52-week high 33.5300
52-week low 30.2500
50-day moving average 31.0310
200-day moving average 31.8774

Share statistics

Avg vol (3-month) 31.75M
Avg vol (10-day) 3955.49k
Shares outstanding 564.46M
Implied shares outstanding 664.46M
Float 840.48M
% held by insiders 13.08%
% held by institutions 151.81%
Shares short (15 May 2024) 42.34M
Short ratio (15 May 2024) 40.69
Short % of float (15 May 2024) 45.23%
Short % of shares outstanding (15 May 2024) 43.63%
Shares short (prior month 15 Apr 2024) 43.01M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-394,493.04%

Management effectiveness

Return on assets (ttm)-47.82%
Return on equity (ttm)-81.84%

Income statement

Revenue (ttm)10k
Revenue per share (ttm)0.00
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -39.33M
Net income avi to common (ttm)-37.28M
Diluted EPS (ttm)-0.5800
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)31.28M
Total cash per share (mrq)0.49
Total debt (mrq)630.83k
Total debt/equity (mrq)2.18%
Current ratio (mrq)6.28
Book value per share (mrq)0.45

Cash flow statement

Operating cash flow (ttm)-33.78M
Levered free cash flow (ttm)-20.97M